Skip to main content

and
  1. No Access

    Article

    Clinic-based perspectives on the integration of patient-reported outcomes (PROs) in a tertiary cancer center

    This study examines providers’ and clinic staff’s perspectives on patient-reported outcomes (PROs) implementation at an academic medical center.

    Nada Al-Antary, Kelly A. Hirko, Farah Elsiss, Theresa Zatirka in Supportive Care in Cancer (2024)

  2. No Access

    Article

    Lifetime alcohol consumption patterns and young-onset breast cancer by subtype among Non-Hispanic Black and White women in the Young Women’s Health History Study

    The role of alcohol in young-onset breast cancer (YOBC) is unclear. We examined associations between lifetime alcohol consumption and YOBC in the Young Women’s Health History Study, a population-based case–con...

    Kelly A. Hirko, Darek R. Lucas, Dorothy R. Pathak in Cancer Causes & Control (2024)

  3. Article

    Open Access

    Rural patient and provider perceptions of telehealth implemented during the COVID-19 pandemic

    Understanding perceptions of telehealth  implementation from patients and providers can improve the utility and sustainability of these programs, particularly in under-resourced rural settings. The purpose of ...

    David Klee, Derek Pyne, Joshua Kroll, William James in BMC Health Services Research (2023)

  4. No Access

    Article

    Provider Confidence and Perceived Barriers when Recommending the Human Papillomavirus Vaccine to Parents

    Provider recommendation for the HPV vaccine is considered a critical determinant of vaccine uptake compared to other interventions such as parent education. However, providers cite continued barriers to discu...

    Taylar Dickson, Kelly A. Hirko, Sabrina Ford in Journal of Cancer Education (2023)

  5. No Access

    Article

    Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study

    To evaluate the association between lifetime personal cigarette smoking and young-onset breast cancer (YOBC; diagnosed <50 years of age) risk overall and by breast cancer (BC) subtype, and whether risk varies ...

    Ugonna Ihenacho, Ann S. Hamilton, Wendy J. Mack in Breast Cancer Research and Treatment (2022)

  6. No Access

    Article

    Cancer disparities in the context of rurality: risk factors and screening across various U.S. rural classification codes

    Prior cancer research is limited by inconsistencies in defining rurality. The purpose of this study was to describe the prevalence of cancer risk factors and cancer screening behaviors across various county-ba...

    Kelly A. Hirko, Huiwen Xu, Laura Q. Rogers, Michelle Y. Martin in Cancer Causes & Control (2022)

  7. Article

    Open Access

    The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology

    Breast cancer is the most commonly diagnosed cancer worldwide and is one of the leading causes of cancer death. The incidence, pathological features, and clinical outcomes in breast cancer differ by geographic...

    Kelly A. Hirko, Gabrielle Rocque, Erica Reasor, Ammanuel Taye, Alex Daly in BMC Medicine (2022)

  8. Article

    Open Access

    Glucocorticoids and breast cancer risk

    Kelly A. Hirko, A. Heather Eliassen in BMC Medicine (2021)

  9. No Access

    Article

    Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program

    While racial disparities in inflammatory breast cancer (IBC) incidence are fairly well documented, with black women having significantly higher rates compared to white women; less is known about whether IBC pr...

    Abdi T. Gudina, Glenn Copeland, Amr S. Soliman in Breast Cancer Research and Treatment (2019)

  10. No Access

    Article

    Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses’ Health Study

    Ki67 is a proliferation marker commonly assessed by immunohistochemistry in breast cancer, and it has been proposed as a clinical marker for subtype classification, prognosis, and prediction of therapeutic res...

    Megan A. Healey, Kelly A. Hirko, Andrew H. Beck in Breast Cancer Research and Treatment (2017)

  11. No Access

    Article

    Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses’ Health Study and Nurses’ Health Study II

    Findings from epidemiologic studies of oxidative stress biomarkers and breast cancer have been mixed, although no studies have focused on estrogen receptor-negative (ER−) tumors which may be more strongly asso...

    Kelly A. Hirko, Renée T. Fortner in Breast Cancer Research and Treatment (2016)

  12. No Access

    Article

    Healthy dietary patterns and risk of breast cancer by molecular subtype

    We examined associations between dietary quality indices and breast cancer risk by molecular subtype among 100,643 women in the prospective Nurses’ Health Study (NHS) cohort, followed from 1984 to 2006. Dieta...

    Kelly A. Hirko, Walter C. Willett in Breast Cancer Research and Treatment (2016)

  13. Article

    Open Access

    Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988–2008)

    Inflammatory breast cancer (IBC) is characterized by an apparent geographical distribution in incidence, being more common in North Africa than other parts of the world. Despite the rapid growth of immigrants ...

    Kelly A Hirko, Amr S Soliman, Mousumi Banerjee, Julie Ruterbusch in SpringerPlus (2013)